The next generation sequencing market offers significant opportunities by enhancing the diagnosis and treatment of chronic ...

Revvity targets 2026 growth with multiomics, AI-powered base editing, NGS newborn screening, and immunotherapy advances.

Recent industry reports have highlighted past and projected rapid expansion in the DNA diagnostics and genomics markets, driven by liquid biopsies, direct-to-consumer testing, and personalized ...

The global genomics market is set to expand from USD 47.07 billion in 2025 to USD 85.09 billion by 2030, with a CAGR of 12.6% ...

Liquid biopsy is increasingly recognized as a promising tool for cancer detection and treatment monitoring, yet its ...

This article is all about what’s new and what it might mean for us, covering the latest in genetics in news. New methods like ...

Liquid biopsy is increasingly recognized as a promising tool for cancer detection and treatment monitoring, yet its ...

The lore of subspace dates back to the very earliest years of "Star Trek." But what does this concept mean, and how is it ...

The NBDL represents a transition from observing nature as something external to something that is molecularly intimate.

OmniAb, Inc. (NASDAQ: OABI) today announced it will hold a virtual investor event to showcase the launch of OmniUltra™ on ...

ServerDomes is partnering with Global Green Generation, a global engineering and construction management organization specializing in high-efficiency, AI-ready data center design and delivery, to ...

MUTE-Seq is a new liquid-biopsy method powered by an engineered ultra-precise CRISPR enzyme, FnCas9-AF2, which can distinguish single-base mismatches across all sgRNA positions with near-zero ...